Markets:

Overview

News

Currencies

International

Treasuries

Oragenics Inc. Common Stock (NY:OGEN)

0.6768 UNCHANGED

Streaming Delayed Price Updated: 8:00 PM EDT, Apr 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Oragenics Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Crude Oil Down 1%; Dollar Tree Shares Tumble After Downbeat Earnings ↗

September 04, 2024

Via Benzinga

Why Oragenics (OGEN) Stock Is Getting Hammered ↗

September 04, 2024

Oragenics shares are trading lower by 47% during Wednesday's session. The company announced a $4.45 million public offering.

Via Benzinga

US Stocks Mixed; Trade Gap Widens In July ↗

September 04, 2024

Via Benzinga

Why GitLab Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗

September 04, 2024

Via Benzinga

InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Completes Manufacture, Filling of Intranasal Device for Use in Upcoming Clinical Trial

August 21, 2024

Via Investor Brand Network

OGEN Stock Earnings: Oragenics Reported Results for Q2 2024 ↗

August 12, 2024

Oragenics just reported results for the second quarter of 2024.

Via InvestorPlace

OGEN Stock Earnings: Oragenics Reported Results for Q4 2023 ↗

June 28, 2024

Oragenics just reported results for the fourth quarter of 2023.

Via InvestorPlace

EXCLUSIVE: Oragenics Completes Spray Dry Drug Manufacturing, Intranasal Device Filling For Anticipated Mid-Stage Study For Patients With Brain Injury ↗

August 21, 2024

Oragenics completes the formulation and filling of its nasal spray drug, ONP-002, for concussion treatment, aiming to launch a Phase 2a trial.

Via Benzinga

BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Reports on Status of Lead Drug Candidate Designed to Treat Concussion

August 19, 2024

Via Investor Brand Network

“Explosive Growth Stocks: Innovations, Strategy, Earners Unlock Prime Potential CXAI, OGEN, PRSO, INBS, KAVL”

August 14, 2024

Via AB Newswire

Topics Artificial Intelligence

As Traumatic Brain Injuries Increase, Global Concussion Market Size Expected to Reach $10 Billion By 2032

August 09, 2024

EQNX::TICKER_START (NYSE:OGEN),(NYSE:ABT),(NASDAQ:BIIB),(NYSE:PFE),(NYSE:ABBV) EQNX::TICKER_END

Via FinancialNewsMedia

Why Oragenics (OGEN) Shares Are Falling ↗

June 25, 2024

Oragenics shares are trading lower by 21% during Tuesday's session. The company announced pricing of its public offering.

Via Benzinga

OGEN Stock Earnings: Oragenics Reported Results for Q1 2024 ↗

May 15, 2024

Oragenics just reported results for the first quarter of 2024.

Via InvestorPlace

EXCLUSIVE: Oragenics' Concussion Drug Clears FDA-Required Cardiotoxicity Testing, Planning For Phase Trials Underway ↗

August 08, 2024

Oragenics announced its lead candidate, ONP-002, for treating concussion, which shows no cardiotoxicity in studies. Designed for nasal delivery to the brain, ONP-002 aims to address the significant...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

June 25, 2024

Pre-market stock movers are worth checking out on Tuesday as we get into all of the hottest news worth reading about this morning!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

June 05, 2024

Via Benzinga

Nasdaq Falls Over 100 Points; TJX Posts Upbeat Q1 Results ↗

May 22, 2024

Via Benzinga

Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

May 22, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 22, 2024

Via Benzinga

Gold Down Over 1%; Williams-Sonoma Posts Strong Earnings ↗

May 22, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 13, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 07, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 07, 2024

Via Benzinga

Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards

April 19, 2024

From Oragenics, Inc.

Via Business Wire

Oragenics, Inc. Files 10K and Provides Company Update

April 01, 2024

From Oragenics, Inc.

Via Business Wire

Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion

March 18, 2024

From Oragenics, Inc.

Via Business Wire

Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion

March 05, 2024

From Oragenics, Inc.

Via Business Wire

Oragenics Announces Closing of Public Offering

March 01, 2024

From Oragenics, Inc.

Via Business Wire

S&P 500 Edges Lower; ADT Posts Upbeat Earnings ↗

February 28, 2024

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow traded down 0.27% to 38,867.91 while the NASDAQ fell 0.50% to 15,954.75. The...

Via Benzinga

Topics Stocks

Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 28, 2024

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.